Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan 19;12(1):e0004.
doi: 10.5041/RMMJ.10428.

Oral Biofilm: Development Mechanism, Multidrug Resistance, and Their Effective Management with Novel Techniques

Affiliations
Review

Oral Biofilm: Development Mechanism, Multidrug Resistance, and Their Effective Management with Novel Techniques

Shakti Rath et al. Rambam Maimonides Med J. .

Abstract

Biofilms are formed by the congregation of one or more types of microorganisms that can grow on a firm surface. Dental plaque is one of the most commonly forming biofilms in the oral cavity and appears as a slimy layer on the surface of the teeth. In general, the formation is slow, but biofilms are very adaptive to the changing environment, and a mature biofilm can cause many health-related problems in humans. These biofilms remain unaffected by antibiotics as they do not allow the penetration of antibiotics. Moreover, the increased level of virulence and antibiotic resistance of microorganisms in the oral biofilm or dental plaque has made its clinical management a serious challenge worldwide. Chlorhexidine-like antimicrobial drugs have been partially effective in removing such organisms; however, the precise and continuous elimination of these microorganisms without disturbing the normal microbial flora of the oral cavity is still a challenge. This review paper focuses on the process of oral biofilm formation, related complications, development of drug-resistant bacteria in these biofilms, and their effective management by the use of different novel techniques, available from various published research and review articles.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: No potential conflict of interest relevant to this article was reported.

Figures

Figure 1
Figure 1
Schematic Description of Stages 1–3 of Biofilm Formation. Stage 1: Entry of multidrug-resistant pathogenic bacteria, commensals, and oral microflora. Stage 2: The salivary pellicle begins to form as the commensals and pathogenic bacteria congregate, laying the foundation for biofilm development. Stage 3: The bacteria rapidly multiply and begin to adhere, and dysbiosis begins.
Figure 2
Figure 2
Schematic Description of Stages 4 and 5 of Biofilm Formation. Stage 4: The biofilm matures, there is an exchange of drug-resistant genes, and complete dysbiosis. Stage 5: With the full maturation of the biofilm, new multidrug-resistant bacteria are released into the oral cavity, spreading the oral biofilm.

References

    1. Berger D, Rakhamimova A, Pollack A, Loewy Z. Oral biofilms: development, control, and analysis. High Throughput. 2018;7:24. doi: 10.3390/ht7030024. - DOI - PMC - PubMed
    1. Bowen WH, Burne RA, Wu H, Koo H. Oral biofilms: pathogens, matrix, and polymicrobial interactions in microenvironments. Trends Microbiol. 2018;26:229–42. doi: 10.1016/j.tim.2017.09.008. - DOI - PMC - PubMed
    1. Pasich E, Walczewska M, Pasich A, Marcinkiewicz J. Mechanism and risk factors of oral biofilm formation. Postepy Hig Med Dosw (Online) 2013;67:736–41. doi: 10.5604/17322693.1061393. [Article in Polish] - DOI - PubMed
    1. Singh S, Singh SK, Chowdhury I, Singh R. Understanding the mechanism of bacterial biofilms resistance to antimicrobial agents. Open Microbiol J. 2017;11:53–62. doi: 10.2174/1874285801711010053. - DOI - PMC - PubMed
    1. Kriebel K, Hieke C, Müller-Hilke B, Nakata M, Kreikemeyer B. Oral Biofilms from symbiotic to pathogenic interactions and associated disease-connection of periodontitis and rheumatic arthritis by peptidylarginine deiminase. Front Microbiol. 2018;9:53. doi: 10.3389/fmicb.2018.00053. - DOI - PMC - PubMed

LinkOut - more resources